Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00453739
Other study ID # 300-06-006
Secondary ID
Status Completed
Phase N/A
First received March 28, 2007
Last updated May 5, 2014
Start date February 2007
Est. completion date June 2010

Study information

Verified date May 2014
Source Ethicon, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review BoardFrance: Institutional Ethical CommitteeUnited Kingdom: Research Ethics CommitteeAustria: EthikkommissionGermany: Ethics CommissionItaly: Ethics CommitteeFinland: Ethics CommitteeSpain: Ethics CommitteeSouth Africa: National Health Research Ethics CouncilAustralia: Human Research Ethics CommitteeSouth Korea: Institutional Review Board
Study type Observational

Clinical Trial Summary

The objective of this observational study is to obtain long -term clinical and patient reported outcomes on the use of the GYNECARE family of TVT (Tension-Free Vaginal Tape) systems in women with stress urinary incontinence.


Description:

Sites may include patients with either the GYNECARE TVT SECUR System, GYNECARE TVT System, or the GYNECARE TVT Obturator System


Recruitment information / eligibility

Status Completed
Enrollment 1407
Est. completion date June 2010
Est. primary completion date June 2010
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Women diagnosed with SUI who are suitable candidates for a TVT system, as according the relevant Instructions for Use (IFU).

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Locations

Country Name City State
Australia The Townsville Hospital Department of Urogynaecology Douglas
Australia Gold Coast Health Service Southport
Australia Queen Elizabeth Hospital Woodville
Austria Abteilung fuer Gynaekologie Moedling
Canada Wentworth-Limeridge Medical Centre Hamilton Ontario
Germany Universitatsfrauenklinik Tubingen
Korea, Republic of Samsung Medical Center Seoul
Singapore Kandang Kerbau Women's and Children's Hospital Singapore
South Africa Kingsbury House Cape Town
South Africa Pretoria Urology Hospital Hatfield
South Africa Arwyp Hospital Kempton
United Kingdom Ulster Hospital Belfast Belfast
United Kingdom Stoke Mandeville Hospital Buckinghamshire
United Kingdom Glasgow Southern General Glasgow
United Kingdom Leicester General Hospital Leicester
United States The Institute for Female Pelvic Medicine and Reconstructive Surgery Allentown Pennsylvania
United States Northern Virginia Pelvic Surgery Associates Annandale Virginia
United States Michigan Institute of Women's Health Dearborn Michigan
United States Southern California Permanente Medical Group Downey California
United States Sound Urological Associates Edmonds Washington
United States Milestone Medical Research Englewood Colorado
United States Women's Health Center of West Michigan Grand Rapids Michigan
United States Sheldon J. Freedman MD Las Vegas Nevada
United States Female Pelvic Medicine & Reconstructive Surgery Minneapolis Minnesota
United States Specialists in Urology Naples Florida
United States Vanderbilt University Medical School Nashville Tennessee
United States Illinois Urogynecology LTD Oak Lawn Illinois
United States University of Rochester OB/Gyn Department Rochester New York
United States Seton Center, Good Samaritan Hospital West Chester Ohio
United States Advanced Clinical Concepts West Reading Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Ethicon, Inc.

Countries where clinical trial is conducted

United States,  Australia,  Austria,  Canada,  Germany,  Korea, Republic of,  Singapore,  South Africa,  United Kingdom, 

References & Publications (1)

Tincello DG, Botha T, Grier D, Jones P, Subramanian D, Urquhart C, Kirkemo A, Khandwala S; TVT Worldwide Registry Investigators. The TVT Worldwide Observational Registry for Long-Term Data: safety and efficacy of suburethral sling insertion approaches for — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Standing cough stress test 12 months No
Secondary I-QOL score 3, 6, 12 and 24 months No
See also
  Status Clinical Trial Phase
Recruiting NCT04829357 - Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
Completed NCT05493735 - Lidocaine for Pessary Check Pain Reduction Phase 3
Completed NCT04512053 - A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence Phase 2
Active, not recruiting NCT06224335 - Measurement of Intravaginal and Intra-abdominal Pressure and Pad Test During Sports Activities (SPORTVAGPRES)
Recruiting NCT05304312 - The Role of Kegel Exercises Book to Improve Treatment in Stress Urinary Incontinence Women N/A
Not yet recruiting NCT05527665 - Sexual Fonction and Discomfort in Women After Midurethral Sling Surgery, Using PPSSQ
Not yet recruiting NCT04558762 - Ten Years Follow-up After Insertion of a MUS (Mid Urethral Sling) Due to Stress Urinary Incontinence
Withdrawn NCT02524366 - A Study of Transcorporal Versus Standard Artificial Urinary Sphincter Placement N/A
Completed NCT01924728 - Efficacy of Magnetic Stimulation for Stress Urinary Incontinence N/A
Completed NCT01676662 - Solace European Confirmatory Trial N/A
Unknown status NCT01455779 - Lyrette: Renewing Continence Objective and Subjective Efficacy Study N/A
Terminated NCT01029106 - Gynecare TVT Secur for the Management of Stress Urinary Incontinence (SUI) N/A
Withdrawn NCT00573703 - Laparoscopic Burch Colposuspension Versus Transobturatory Tape for the Treatment of Female Urinary Stress Incontinence Phase 4
Completed NCT01123096 - Is the Cough Stress Test Equivalent to the 24 Hour Pad Test in the Assessment of Stress Incontinence? N/A
Completed NCT01770691 - Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence N/A
Completed NCT00234754 - Trans-Obturator Tape Versus Trans-Vaginal Tape for Stress Urinary Incontinence in Women N/A
Completed NCT00441454 - Retropubic vs. Transobturator Tension-free Vaginal Tape N/A
Completed NCT03985345 - Prospective Evaluation of the Connected EMY Biofeedback Probe in the Management of Stress Urinary Incontinence. N/A
Active, not recruiting NCT03671694 - Laser Vaginal Treatment for SUI N/A
Completed NCT04097288 - Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects Phase 1